ArticleFrontiers in immunology2021

Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.

Daniel E Pleguezuelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.